New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
How to increase the chance of survival in older patients with head and neck cancer

How to increase the chance of survival in older patients with head and neck cancer

byLeipzig UniversityOverall Survival of Older Patients (≥65 Years) With Head and Neck Squamous Cell Carcinoma Receiving Radiotherapy (RT) Alone or With Concomitant Systemic Treatment A, RT vs RT
World medicine December 14,2023
How to increase the chance of survival in older patients with head and neck cancer

How to increase the chance of survival in older patients with head and neck cancer

byLeipzig UniversityOverall Survival of Older Patients (≥65 Years) With Head and Neck Squamous Cell Carcinoma Receiving Radiotherapy (RT) Alone or With Concomitant Systemic Treatment A, RT vs RT
World medicine December 14,2023
Brain organoids reveal glioblastoma origins

Brain organoids reveal glioblastoma origins

by Nicholas Weiler,University of California, San FranciscoGlioblastoma cells (green) invade a brain organoid grown from human stem cells (blue). Credit: University of California, San FranciscoGl
World medicine December 14,2023
Brain organoids reveal glioblastoma origins

Brain organoids reveal glioblastoma origins

by Nicholas Weiler,University of California, San FranciscoGlioblastoma cells (green) invade a brain organoid grown from human stem cells (blue). Credit: University of California, San FranciscoGl
World medicine December 14,2023
Autophagy genes act as tumor suppressors in ovarian cancer

Autophagy genes act as tumor suppressors in ovarian cancer

byMedical University of South CarolinaJoseph Delaney, Ph.D., collaborated with MUSC researchers and others to examine the role of autophagy genes in ovarian cancer. Credit: Vagney Bradley of Mus
World medicine December 14,2023
Autophagy genes act as tumor suppressors in ovarian cancer

Autophagy genes act as tumor suppressors in ovarian cancer

byMedical University of South CarolinaJoseph Delaney, Ph.D., collaborated with MUSC researchers and others to examine the role of autophagy genes in ovarian cancer. Credit: Vagney Bradley of Mus
World medicine December 14,2023
AI equals human radiologists at interpreting breast cancer scans

AI equals human radiologists at interpreting breast cancer scans

by Amy NortonAnother study is showing that artificial intelligence (AI) is as good as a specialist doctor in spotting breast cancer on a mammogram. But don't expect computers to take over the job
World medicine December 14,2023
AI equals human radiologists at interpreting breast cancer scans

AI equals human radiologists at interpreting breast cancer scans

by Amy NortonAnother study is showing that artificial intelligence (AI) is as good as a specialist doctor in spotting breast cancer on a mammogram. But don't expect computers to take over the job
World medicine December 14,2023
Combination drug therapy for childhood brain tumors shows promise in laboratory models

Combination drug therapy for childhood brain tumors shows promise in laboratory models

byJohns Hopkins University School of MedicineCredit: CC0 Public DomainIn experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combini
World medicine December 14,2023
Combination drug therapy for childhood brain tumors shows promise in laboratory models

Combination drug therapy for childhood brain tumors shows promise in laboratory models

byJohns Hopkins University School of MedicineCredit: CC0 Public DomainIn experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combini
World medicine December 14,2023
AI predictions for colorectal cancer: One step closer to efficient precision oncology

AI predictions for colorectal cancer: One step closer to efficient precision oncology

by Luisa Hoffmann,Helmholtz Association of German Research CentresCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.08.002Colorectal cancer (CRC) ranks second in leading causes of
World medicine December 14,2023
AI predictions for colorectal cancer: One step closer to efficient precision oncology

AI predictions for colorectal cancer: One step closer to efficient precision oncology

by Luisa Hoffmann,Helmholtz Association of German Research CentresCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.08.002Colorectal cancer (CRC) ranks second in leading causes of
World medicine December 14,2023
Hormone therapy now available for newly diagnosed prostate cancer in Scotland

Hormone therapy now available for newly diagnosed prostate cancer in Scotland

byCancer Research UKMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0A hormone therapy will now be available for s
World medicine December 14,2023
Hormone therapy now available for newly diagnosed prostate cancer in Scotland

Hormone therapy now available for newly diagnosed prostate cancer in Scotland

byCancer Research UKMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0A hormone therapy will now be available for s
World medicine December 14,2023
Cell network mapping reveals rewiring in colorectal cancer

Cell network mapping reveals rewiring in colorectal cancer

by South Australian Health and Medical Research Institute (SAHMRI)Credit: AI-generated imageAn international consortium of researchers from Australia, Ireland, the UK, Europe, and Canada, has painstak
World medicine December 14,2023
Cell network mapping reveals rewiring in colorectal cancer

Cell network mapping reveals rewiring in colorectal cancer

by South Australian Health and Medical Research Institute (SAHMRI)Credit: AI-generated imageAn international consortium of researchers from Australia, Ireland, the UK, Europe, and Canada, has painstak
World medicine December 14,2023
AI helpful in triaging breast masses in low-resource areas

AI helpful in triaging breast masses in low-resource areas

byRadiological Society of North AmericaImages in a 37-year-old woman show a palpable mass due to low-grade ductal carcinoma in situ. (A) Orthogonal portable US images show a hypoechoic oval mass
World medicine December 14,2023
AI helpful in triaging breast masses in low-resource areas

AI helpful in triaging breast masses in low-resource areas

byRadiological Society of North AmericaImages in a 37-year-old woman show a palpable mass due to low-grade ductal carcinoma in situ. (A) Orthogonal portable US images show a hypoechoic oval mass
World medicine December 14,2023
More time between prostate cancer screenings could improve outcomes

More time between prostate cancer screenings could improve outcomes

byOxford University PressMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0A new study inJNCI: Journal of the
World medicine December 14,2023
More time between prostate cancer screenings could improve outcomes

More time between prostate cancer screenings could improve outcomes

byOxford University PressMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0A new study inJNCI: Journal of the
World medicine December 14,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com